The socio-economic value of adult immunization (OHE)(Poster)
This study by the Office of Health Economics (OHE) synthesizes existing evidence for the broad, socio-economic value of adult immunization programs, focusing on influenza, pneumococcal, herpes zoster (HZ), and respiratory syncytial virus (RSV) programs in ten countries (Australia, Brazil, France, Germany, Italy, Japan, Poland, South Africa, Thailand, United States).
In a forthcoming publication, OHE will present the results of a cost-benefit analysis to quantify the socio-economic return on investment for vaccination programs in these countries. The Poster has been presented at the ISPOR Europe 2023 Conference on 12-15 November in Copenhagen.
This study was commissioned by IFPMA.